# Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD

> **NCT06841640** · PHASE1,PHASE2 · COMPLETED · sponsor: **AeroRx Therapeutics Inc.** · enrollment: 24 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** AERO-001
- **DRUG:** AERO-002
- **DRUG:** AERO-007

## Key facts

- **NCT ID:** NCT06841640
- **Lead sponsor:** AeroRx Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-15
- **Primary completion:** 2025-05-20
- **Final completion:** 2025-06-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06841640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06841640, "Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06841640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*